Tetrahydropyridopyrimidines for the treatment and prophylaxis of hepatitis B virus infection
US10968217B2 · kind B2 · utility
0Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 1, 2017 |
| Grant date | Apr 6, 2021 |
| Priority date | — |
| Expiry date | Nov 1, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel compounds having the general formula (I) wherein R1, R2 and Z are as described herein, compositions including the compounds and methods of using the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.